Clinical characteristics in 3 patients treated for TMA following IV abuse of extended-release oxymorphone
| . | Patient 1 . | Patient 2 . | Patient 3 . |
|---|---|---|---|
| Age, y | 24 | 28 | 48 |
| Sex | Female | Male | Female |
| Presenting symptoms | Numbness of extremities, vision loss | Angina, dyspnea, abdominal pain, vision loss | Angina, dyspnea, abdominal pain, diarrhea, numbness of extremities, vision loss |
| Treatment | 5 times plasma exchange | 9 times plasma exchange | 5 times plasma exchange |
| . | Patient 1 . | Patient 2 . | Patient 3 . |
|---|---|---|---|
| Age, y | 24 | 28 | 48 |
| Sex | Female | Male | Female |
| Presenting symptoms | Numbness of extremities, vision loss | Angina, dyspnea, abdominal pain, vision loss | Angina, dyspnea, abdominal pain, diarrhea, numbness of extremities, vision loss |
| Treatment | 5 times plasma exchange | 9 times plasma exchange | 5 times plasma exchange |